⁶⁸Ga-PSMA PET/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular Extension and Seminal Vesicle Invasion Prior to Radical Prostatectomy in Patients with Prostate Cancer
10.1007/s13139-017-0476-7
- Author:
Christoph Alexander J VON KLOT
1
;
Axel S MERSEBURGER
;
Alena BÖKER
;
Sebastian SCHMUCK
;
Tobias L ROSS
;
Frank M BENGEL
;
Markus A KUCZYK
;
Christoph HENKENBERENS
;
Hans CHRISTIANSEN
;
Hans Jürgen WESTER
;
Wiebke SOLASS
;
Marcel LAFOS
;
Thorsten DERLIN
Author Information
1. Department of Urology and Urological Oncology, HannoverMedical School, Hannover, Germany. klot.christoph@mh-hannover.de
- Publication Type:Original Article
- Keywords:
Prostate-specific membrane antigen (PSMA);
PET/CT;
Prostate cancer;
Staging;
Seminal vesicle;
Extracapsular extension
- MeSH:
Electrons;
Humans;
Membranes;
Neoplasm Grading;
Pilot Projects;
Positron-Emission Tomography and Computed Tomography;
Prostate;
Prostate-Specific Antigen;
Prostatectomy;
Prostatic Neoplasms;
Recurrence;
Seminal Vesicles;
Sensitivity and Specificity;
Tumor Burden
- From:Nuclear Medicine and Molecular Imaging
2017;51(4):314-322
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: ⁶⁸Ga-labeled prostate-specific membrane antigen (PSMA) ligand positron emission tomography/computed tomography (PET/CT) has shown promising results in patients with biochemical recurrence after primary therapy for prostate cancer. In this study, we evaluated the usefulness of PSMA I&T (imaging and therapy) PET/CT prior to radical prostatectomy.METHODS: The study population consisted of 21 patients with prostate cancer who underwent ⁶⁸Ga-PSMA I&T PET/CT before either open or laparoscopic radical prostatectomy. Intraprostatic tumor extent, extracapsular extension (ECE) and seminal vesicle invasion (SVI) were assessed on the PET/CT scans. Tracer uptake was quantified in terms of standardized uptake values (SUVs). Imaging findings were correlated with final whole-gland histopathology.RESULTS: Of the 21 patients, two had T stage 2b disease, nine stage 2c, six stage 3a and four stage 3b. The median Gleason score was 7. The SUV(mean) of the primary tumors was 9.5 ± 8.8. SUV(mean) was higher in tumors with ECE than in organconfined tumors (13.8 ± 11.0 vs. 5.6 ± 3.2, p = 0.029). Peak tracer uptake was significantly positively correlated with Gleason score (r(s) = 0.49, p = 0.025). Sensitivity, specificity, positive predictive value and negative predictive value were, respectively, 94.7%, 75.0%, 97.3% and 60.0% for tumor infiltration of an individual prostate lobe, 75.0%, 100.0%, 100.0% and 97.4% for SVI, and 90.0%, 90.9%, 90.0% and 90.9% for ECE, using an angulated contour of the prostate as the criterion. Tumor volume derived from ⁶⁸Ga-PSMA I&T PET/CT was significantly correlated with preoperative prostate-specific antigen value (r(p) = 0.75, p < 0.001) and tumor volume on histopathology (r(p) = 0.45, p = 0.039).CONCLUSIONS: ⁶⁸Ga-PSMA I&T PET/CT prior to radical prostatectomy can contribute to presurgical local staging of prostate cancer. In this pilot study, ⁶⁸Ga-PSMA I&T PET/CT showed promising results for prediction of lobe infiltration, ECE and SVI.
